UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

Filed by the Registrant         ☒         Filed by a party other than the Registrant         ☐

 

Check the appropriate box:

 

☐         Preliminary Proxy Statement

 

☐         Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

☐         Definitive Proxy Statement

 

☒         Definitive Additional Materials

 

☐         Soliciting Material under 240.14a-12

 

OPKO Health, Inc.

 

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box)

 

☒         No fee required

 

☐         Fee paid previously with preliminary materials.

 

☐         Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

opk20250314_defa14aimg001.jpg

 

 

 

 

 

opk20250314_defa14aimg002.jpg

 

 

Opko Health (NASDAQ:OPK)
Historical Stock Chart
From Mar 2025 to Mar 2025 Click Here for more Opko Health Charts.
Opko Health (NASDAQ:OPK)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Opko Health Charts.